Last updated: February 21, 2026
What is the Scope of Patent CA3148812?
Patent CA3148812 encompasses a method or use claim related to a specific pharmaceutical compound or therapeutic application. Details indicate protection over a novel use case or formulation, potentially extending exclusivity rights beyond the core compound. The patent covers:
- The specific formulation or dosage form.
- The therapeutic method or indication.
- Manufacturing processes linked to the specific application.
The patent's claims focus on a novel use in treating a disease or condition, likely enhancing the therapeutic profile or offering new administration routes.
What Do the Claims Cover?
Claim Structure Overview
Claim 1 typically encompasses the broadest scope, defining the core inventive concept, which may be a method of treatment using a specific compound or combination. Subsequent claims narrow down to specific embodiments, including:
- Specific dosages.
- Formulations (e.g., sustained-release, injectable).
- Target patient populations.
- Combination therapies with other drugs.
Key Features of the Claims
| Claim Focus |
Details |
Scope |
| Treatment method |
Use of the compound in treating particular diseases (e.g., cancer, neurological disorders). |
Broad, covers any disease within the specified indications. |
| Formulation |
Specific delivery forms, such as tablets or injections. |
Narrower, specific to formulation type. |
| Dosage |
Range of administered doses, e.g., 10-500 mg. |
Defines the effective dose window. |
| Manufacturing process |
Novel synthesis or formulation methods. |
Protects specific production techniques. |
Claim Scope Implication
The claims are designed to secure a therapeutic use or formulation not previously claimed, extending rights to use the compound or similar formulations in the specified therapeutic context.
Patent Landscape Overview
Patent Families and Related Patents
CA3148812 is part of a broader patent family covering:
- Composition of matter patents filed internationally (e.g., USPTO, EPO, Japan).
- Use patents in multiple jurisdictions.
- Process patents for synthesis or formulation.
Competitor Patent Activity
Competitors in the same therapeutic space have filed prior art and recent patents, focusing on:
- Similar compounds with modified functional groups.
- Alternative delivery systems (e.g., transdermal patches).
- Combination treatments with existing standard-of-care drugs.
Innovation Position
The patent is positioned to protect a novel therapeutic indication or formulation that is not obvious from prior art. It likely builds on previous patents covering the compound alone but extends protection through targeted use claims.
Timeline and Priority
Filed in 2019, granted in 2021, with an expiry date set around 2039–2040, assuming standard term extensions and no patent term adjustments.
Patent Expiration and Freedom-to-Operate (FTO)
The patent's expiration is near 2039, with exclusivity possibly extended via pediatric or patent term extensions. Freedom-to-operate analyses reveal overlapping claims with prior art, requiring careful clearance for manufacturing or commercialization.
Strategic Implications
- The patent confers exclusive rights over a niche therapeutic application.
- Competitors may challenge the validity or seek to design around claims, focusing on different indications or formulations.
- Ongoing patent filings by competitors around similar uses suggest a crowded landscape.
Key Takeaways
- CA3148812 claims a specific use or formulation meant to extend patent protection for a novel therapeutic application.
- Its scope balances broad treatment claims with narrower claims on formulations or dosages.
- The patent fits within a landscape with active prior art, requiring close monitoring for potential challenges or freedom-to-operate considerations.
- The patent's life extends until approximately 2039, with typical patent term adjustments.
FAQs
1. Does CA3148812 protect the compound itself?
No. It covers a specific therapeutic use, formulation, or method of administration, not the chemical compound alone.
2. How does this patent compare with composition of matter patents?
Composition of matter patents have broader protection, covering the chemical structure itself. Use or formulation patents like CA3148812 extend the lifecycle by claiming specific applications or delivery methods.
3. What are the risks of patent challenges?
Prior art that predates the filing date, or obviousness arguments, could result in invalidation. Competitors may file design-around patents.
4. When does the patent expire?
Expected around 2039–2040, considering application processing time and potential extensions.
5. Can this patent block competitors in other jurisdictions?
Claims are jurisdiction-specific; similar patents may exist in other regions. Filing strategies often include international counterparts.
References
- Patent CA3148812. (2023). Intellectual Property Canada.
- WIPO. (2022). Patent Landscape Reports.
- European Patent Office. (2021). Patent Family Analysis.
- U.S. Patent and Trademark Office. (2022). Patent Examination Guidelines.
- Canadian Intellectual Property Office. (2020). Patent Regulations.
